WeVote
Log In

Bill

Bill

SF 336

A bill for an act relating to the ordering and dispensing of self-administered hormonal contraceptives by a pharmacist pursuant to statewide protocols.

2025-2026 Regular Session Introduced by Molly Donahue and 3 co-sponsors

Authorizes licensed pharmacists to order and dispense FDA-approved self-administered hormonal contraceptives under statewide protocols, expanding access with records.

Subcommittee: Klimesh, Costello, and Trone Garriott.
#contraception #drugs #healthandhumanservicesdepartment #medicalcare #pharmacy #prescriptiondrugs
0
WeVote Research Nonpartisan
Bill Summary · SF 336

Summary of SF 336: Ordering and Dispensing Self-Administered Hormonal Contraceptives by Pharmacists

Overview

SF 336 proposes to authorize licensed pharmacists to order and dispense self-administered hormonal contraceptives to patients under statewide protocols. The protocols would be developed by the Board of Pharmacy in consultation with the Department of Health and Human Services, and must align with existing requirements for record-keeping and patient/provider communications, as well as ongoing pharmacist education.

  • Introduced: February 17, 2025
  • Subcommittee: Klimesh, Costello, and Trone Garriott (final subcommittee action dated February 20, 2025)
  • Status: Under consideration in subcommittee
  • Sponsors: TRONE GARRIOTT (primary), DONAHUE (primary), PETERSEN (primary), ZIMMER (primary)

What the bill would do

  • Authorize pharmacists, under statewide protocols, to order and dispense self-administered hormonal contraceptives to patients.
  • Define “self-administered hormonal contraceptive” as a contraceptive device or medication approved by the U.S. FDA to prevent pregnancy.

Key provisions (as introduced)

  • New authority: A pharmacist may, pursuant to statewide protocols developed by the Board of Pharmacy in consultation with the Department of Health and Human Services and consistent with subsection 3, order and dispense self-administered hormonal contraceptives.
  • Protocols: Statewide protocols would guide how pharmacists may order and dispense these contraceptives, including required practices for:
    • Maintenance of records
    • Notification of health care providers or provision of a written record to the patient
    • Continuing education for pharmacists
  • Definition: The term “self-administered hormonal contraceptive” includes any FDA-approved method used to prevent pregnancy.

Implementation and oversight

  • Protocol development: Board of Pharmacy develops statewide protocols in consultation with the Department of Health and Human Services.
  • Consistency: Protocols must be consistent with requirements in subsection 3 (details of subsection 3 are not included in the provided text).
  • Record-keeping and communication: Protocols must address how records are maintained and how patients or their health care providers are informed or provided with written documentation.

Affected parties

  • Pharmacists: Authorized to order and dispense self-administered hormonal contraceptives under the statewide protocols.
  • Patients: Individuals seeking contraception who would access these products through pharmacies.
  • Health care providers: May be notified or provided with patient records as outlined in the protocols.

Timeline and procedural notes

  • Introduction: February 17, 2025
  • Subcommittee action: February 20, 2025
  • Next steps: Pending further committee consideration, potential floor action and passage through the Legislature. Final enactment would require approval by both legislative chambers and the governor.

Potential impact and considerations

  • Access: Could increase accessibility to contraception by enabling pharmacists to provide self-administered options without a prior physician visit, subject to protocol safeguards.
  • Safeguards: Emphasis on record maintenance, provider notification or patient written records, and required continuing education to ensure safe and informed dispensing.
  • Scope: The approach relies on robust statewide protocols and coordination with health authorities to ensure patient safety and appropriate follow-up care.

Note: The summary reflects the text and explanations provided in the introduced version.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.